Search: onr:"swepub:oai:DiVA.org:umu-172863" >
MicroRNAs in the Pa...
MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
-
Gluud, Maria (author)
-
Willerslev-Olsen, Andreas (author)
-
Gjerdrum, Lise Mette Rahbek (author)
-
show more...
-
Lindahl, Lise M. (author)
-
Buus, Terkild B. (author)
-
Andersen, Mads Hald (author)
-
Bonefeld, Charlotte Menne (author)
-
Krejsgaard, Thorbjorn (author)
-
Litvinov, Ivan V. (author)
-
Iversen, Lars (author)
-
Becker, Jürgen C. (author)
-
- Persson, Jenny L. (author)
- Umeå universitet,Institutionen för molekylärbiologi (Medicinska fakulteten)
-
Koralov, Sergei B. (author)
-
Litman, Thomas (author)
-
Geisler, Carsten (author)
-
Woetmann, Anders (author)
-
Odum, Niels (author)
-
show less...
-
(creator_code:org_t)
- 2020-05-13
- 2020
- English.
-
In: Cancers. - : MDPI. - 2072-6694. ; 12:5
- Related links:
-
https://doi.org/10.3...
-
show more...
-
https://umu.diva-por... (primary) (Raw object)
-
https://www.mdpi.com...
-
https://urn.kb.se/re...
-
https://doi.org/10.3...
-
show less...
Abstract
Subject headings
Close
- Cutaneous T-cell lymphoma (CTCL) represents a heterogeneous group of potentially devastating primary skin malignancies. Despite decades of intense research efforts, the pathogenesis is still not fully understood. In the early stages, both clinical and histopathological diagnosis is often difficult due to the ability of CTCL to masquerade as benign skin inflammatory dermatoses. Due to a lack of reliable biomarkers, it is also difficult to predict which patients will respond to therapy or progress towards severe recalcitrant disease. In this review, we discuss recent discoveries concerning dysregulated microRNA (miR) expression and putative pathological roles of oncogenic and tumor suppressive miRs in CTCL. We also focus on the interplay between miRs, histone deacetylase inhibitors, and oncogenic signaling pathways in malignant T cells as well as the impact of miRs in shaping the inflammatory tumor microenvironment. We highlight the potential use of miRs as diagnostic and prognostic markers, as well as their potential as therapeutic targets. Finally, we propose that the combined use of miR-modulating compounds with epigenetic drugs may provide a novel avenue for boosting the clinical efficacy of existing anti-cancer therapies in CTCL.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- microRNA
- miR
- cutaneous T-cell lymphoma
- CTCL
- mycosis fungoides
- cancer
- tumor suppressor
- oncogene
- biomarker
- targeted therapy
Publication and Content Type
- ref (subject category)
- for (subject category)
Find in a library
-
Cancers
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Gluud, Maria
-
Willerslev-Olsen ...
-
Gjerdrum, Lise M ...
-
Lindahl, Lise M.
-
Buus, Terkild B.
-
Andersen, Mads H ...
-
show more...
-
Bonefeld, Charlo ...
-
Krejsgaard, Thor ...
-
Litvinov, Ivan V ...
-
Iversen, Lars
-
Becker, Jürgen C ...
-
Persson, Jenny L ...
-
Koralov, Sergei ...
-
Litman, Thomas
-
Geisler, Carsten
-
Woetmann, Anders
-
Odum, Niels
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Cancers
- By the university
-
Umeå University